Target intelligence / Profile preview

Bacterial plasma membrane phospholipids

Molecular classification
Lipid, Phospholipid, Membrane lipid, Structural membrane component
01

Overview

Bacterial plasma membrane phospholipids are a diverse group of amphipathic lipids that comprise the primary structural framework of bacterial plasma membranes[2][8]. Each molecule consists of a polar (hydrophilic) head group and nonpolar (hydrophobic) fatty acid tails, spontaneously forming a bilayer in aqueous environments[1][5][6]. In bacteria, these phospholipids vary in chain length, saturation, and composition, affecting membrane properties such as fluidity and charge[2][3][8]. The lipid bilayer acts as a selective barrier between cellular contents and the external environment, supporting membrane protein functions and cellular compartmentalization[1][3][7]. Unlike animal membranes, bacterial membranes usually lack cholesterol[6][8]. Some antimicrobial drugs target these lipids, disrupting barrier function and causing bacterial cell death, but such drugs (e.g., polymyxins) carry risks of toxicity and resistance[8].

Other names
Bacterial membrane phospholipidsBacterial membrane lipidsPhospholipids (in bacterial membrane context)Bacterial lipid bilayer
02

Mechanism of action

Membrane disruption/destabilization (leading to cell lysis) Increased membrane permeability (causing leakage of cellular contents)

03

Biological functions

Membrane barrier formationStructural integrity of cellRegulation of membrane fluidity and permeabilityPlatform for membrane protein localization/activationCompartmentalization of cellular contents
04

Disease associations

Infection (as indirect antibacterial targets, since some antibiotics interact with or disrupt membrane lipids)
05

Safety considerations

Non-selective toxicity (membrane-disrupting drugs may affect host cell membranes at high dose or with improper use)Resistance development (bacteria may alter phospholipid composition in response to membrane-targeting drugs)
06

Interacting drugs

Polymyxins (e.g., colistin, polymyxin B—these bind bacterial membrane phospholipids and destabilize membranes; mainly for Gram-negative bacteria)

2 more in the full profile.

Beyond the preview

Go deeper on Bacterial plasma membrane phospholipids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial plasma membrane phospholipids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call